ECSP13012736A - COMPOSITIONS AND METHODS TO TREAT CANCER USING A PI3K INHIBITOR AND A MEK INHIBITOR - Google Patents

COMPOSITIONS AND METHODS TO TREAT CANCER USING A PI3K INHIBITOR AND A MEK INHIBITOR

Info

Publication number
ECSP13012736A
ECSP13012736A ECSP13012736A ECSP13012736A EC SP13012736 A ECSP13012736 A EC SP13012736A EC SP13012736 A ECSP13012736 A EC SP13012736A EC SP13012736 A ECSP13012736 A EC SP13012736A
Authority
EC
Ecuador
Prior art keywords
inhibitor
compositions
methods
treat cancer
mek
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Echeverria Carlos Garcia
Laurent Debussche
Jianguo Ma
Stuart Mcmillan
Janet Anne Meurer Ogden
Loic Vincent
Original Assignee
Sanofi Sa
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=52666420&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ECSP13012736(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Sa, Merck Patent Gmbh filed Critical Sanofi Sa
Publication of ECSP13012736A publication Critical patent/ECSP13012736A/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se proporcionan procedimientos para tratar pacientes con cáncer, en donde los procedimientos comprenden administrar al paciente una cantidad eficaz de un inhibidor de MEK y una cantidad eficaz de un inhibidor de PI3K. También se describen composiciones en las que los inhibidores de MEK y de PI3K están en combinación.Procedures for treating cancer patients are provided, wherein the procedures comprise administering to the patient an effective amount of an MEK inhibitor and an effective amount of a PI3K inhibitor. Compositions in which the MEK and PI3K inhibitors are in combination are also described.

ECSP13012736 2010-12-09 2013-07-05 COMPOSITIONS AND METHODS TO TREAT CANCER USING A PI3K INHIBITOR AND A MEK INHIBITOR ECSP13012736A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US42146510P 2010-12-09 2010-12-09
US201161436258P 2011-01-26 2011-01-26
US201161467485P 2011-03-25 2011-03-25
FR1159940 2011-11-03

Publications (1)

Publication Number Publication Date
ECSP13012736A true ECSP13012736A (en) 2013-09-30

Family

ID=52666420

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP13012736 ECSP13012736A (en) 2010-12-09 2013-07-05 COMPOSITIONS AND METHODS TO TREAT CANCER USING A PI3K INHIBITOR AND A MEK INHIBITOR

Country Status (1)

Country Link
EC (1) ECSP13012736A (en)

Similar Documents

Publication Publication Date Title
DOP2013000131A (en) COMPOSITIONS AND METHODS TO TREAT CANCER USING A PI3K INHIBITOR AND A MEK INHIBITOR
MX2016004580A (en) USE OF A PCSK9 INHIBITOR TO TREAT HYPERLIPIDEMIA.
PH12021550052A1 (en) Methods of treating and preventing graft versus host disease
MX373925B (en) CANCER TREATMENT WITH TOR KINASE INHIBITORS.
CO6531463A2 (en) COMBINATIONS OF A PI3K INHIBITOR AND A MEK INHIBITOR
MX2020003174A (en) COMBINATION THERAPY COMPRISING A TOR KINASE INHIBITOR AND AN IMID COMPOUND TO TREAT CANCER.
ECSP099376A (en) AKT ACTIVITY INHIBITORS
NI201200090A (en) COMPOSITIONS TO TREAT NAUSEA AND VOMITING CENTRALLY MIDDLE
MX2016015434A (en) Pharmaceutical combinations for treating cancer.
MX2013003076A (en) Breast cancer therapeutics.
NI201400110A (en) CANCER TREATMENT WITH TOR KINASE INHIBITORS
MX374749B (en) COMBINATION THERAPY INCLUDING A TOR KINASE INHIBITOR AND A CYTIDINE ANALOGUE TO TREAT CANCER.
UY33221A (en) METHODS TO TREAT CANCER USING PI3K AND mTOR INHIBITORS IN COMBINATION WITH AUTOPHAGIA INHIBITORS
MX369609B (en) A COMPOSITION FOR USE IN THE TREATMENT OF NMT2-DEFICIENT CANCER.
NI201500055A (en) TREATMENT OF PROSTATE CANCER WITH TOR KINASE INHIBITORS
MX347927B (en) VITAMIN C AND VITAMIN K FREE OF CHROME, AND COMPOSITIONS OF THESE TO TREAT A STATE OR DISEASE IN WHICH NFKB INTERvenes.
ECSP14013244A (en) COMPOSITIONS AND METHODS TO TREAT CANCER USING THE PI3Kbeta INHIBITOR AND THE MAPK ROUTE INHIBITOR, INCLUDING MEK AND RAF INHIBITORS
MX2014003873A (en) Method of treating mucoepidermoid carcinoma.
DOP2014000221A (en) METHODS TO TREAT CANCER USING PI3K INHIBITOR AND MEK INHIBITOR
UY35033A (en) FORMULATION IN TABLETS OF A 3-CINASA PHOSPHYTIDYLINOSITOL INHIBITOR
CO6721062A2 (en) Cmpositions and methods to treat cancer using a pi3k inhibitor and a mek inhibitor
ECSP13012736A (en) COMPOSITIONS AND METHODS TO TREAT CANCER USING A PI3K INHIBITOR AND A MEK INHIBITOR
NI201300052A (en) COMPOSITIONS AND METHODS TO TREAT CANCER USING A PI3K INHIBITOR AND A MEK INHIBITOR
GT201300148A (en) COMPOSITIONS AND METHODS TO TREAT CANCER USING A P13K INHIBITOR AND A MEK INHIBITOR
TN2013000247A1 (en) Compositions comprising a pi3k inhibitor and a mek inhibitor and their use for treating cancer